Preventing heart problems in type 2 diabetes with cilostazol and aspirin
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether taking cilostazol and aspirin together can help prevent heart attacks, strokes, and other cardiovascular events in people with type 2 diabetes who have early signs of artery disease or metabolic syndrome. It aims to see if this combination is more effective than aspirin alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 19 or older
- You have type 2 diabetes and your average blood sugar (HbA1c) is 9.9% or lower
- You have early signs of artery disease (like thickening or stiffness in blood vessels, or calcium buildup in heart arteries) or metabolic syndrome (a cluster of conditions like high blood pressure, high blood sugar, and abnormal cholesterol)
- You have not had a major heart event (like a heart attack or stroke) in the past
- You are not currently taking blood thinners or aspirin
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two blood-thinning drugs (clopidogrel and cilostazol) to see which one better prevents artery problems in people with diabetes and thickened carotid arteries. It may help you if you have diabetes and are already on stable medications.
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
This trial tests whether a daily aspirin and a statin medicine can help prevent heart problems in people with high calcium buildup in their heart arteries. It is for people aged 40 to 75 who have a high coronary calcium score (300 or more) and at least one additional risk factor like diabetes or high blood pressure.
This Phase 3 study tests whether colchicine and a special type of aspirin can lower the risk of future heart attacks, strokes, or other major heart problems in people with type 2 diabetes who have not had a prior heart event. It aims to reduce cardiovascular risk using medicines that may calm inflammation and protect blood vessels.
This trial tests whether cilostazol, a medication that helps keep blood flowing, can prevent another stroke and slow down disease progression in people who have had a recent stroke caused by small vessel disease. It aims to stop the brain damage from getting worse.
This trial tests a heart-focused prevention approach to lower the risk of cardiac (heart) events in adults with type 2 diabetes. It may help by targeting early stress on the heart measured with a specific blood test.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.